Reflux After Sleeve Gastrectomy : Safety and Effectiveness of Laparoscopic Ligamentum Teres Cardiopexy, a Single-Center Experience
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
BACKGROUND: Obesity is a well-known risk factor for gastroesophageal reflux disease (GERD). Even though symptoms may be mitigated or resolved with the weight loss caused by sleeve gastrectomy (SG), it may be associated with higher incidences of postoperative GERD. Ligamentum teres cardiopexy (LTC) is an alternative to Roux-en-Y gastric bypass, the gold standard treatment for GERD.
METHODS: This study was a retrospective single-center chart review, all patients in this cohort underwent LTC to treat refractory GERD at our institution. The option for LTC was presented after patients' refusal to undergo RYGB conversion. We collected baseline characteristics, standard demographics, pre-operative tests and imaging, and SG information, as well as intraoperative and perioperative data regarding LTC, and postoperative complications.
RESULTS: Our cohort included 29 patients; most were Caucasian (44.8%) females (86.2%). The mean weight and BMI before LTC were 216.5 ± 39.3 lb and 36.1 ± 5.4 kg/m2, respectively. Mean total body-weight loss (TBWL) at 12 and 24 months were 28.7% ± 9.5% and 28.4% ± 12.4%, respectively. The mean interval between the index bariatric surgery and LTC was 59.9 ± 34.9 months, mean operative time was 67 ± 18.2 min, and median length of stay (LOS) was 1 day (IQR = 1-2 days). Twelve patients (57.1%) were able to discontinue antisecretory medications, while 9 (42.9%) still required them to remain asymptomatic. Mortality and reoperation rates were 0% and the incidence of complication was 19.4% (n = 6).
CONCLUSIONS: LTC is a safe and effective surgical alternative to treat refractory GERD symptoms after SG.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Obesity surgery - 34(2024), 4 vom: 24. Apr., Seite 1232-1237 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lind, Romulo P [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biliopancreatic diversion with duodenal switch (BPD/DS) |
---|
Anmerkungen: |
Date Completed 19.04.2024 Date Revised 19.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11695-024-07103-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36899581X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36899581X | ||
003 | DE-627 | ||
005 | 20240419232345.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11695-024-07103-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1380.xml |
035 | |a (DE-627)NLM36899581X | ||
035 | |a (NLM)38409622 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lind, Romulo P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Reflux After Sleeve Gastrectomy |b Safety and Effectiveness of Laparoscopic Ligamentum Teres Cardiopexy, a Single-Center Experience |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.04.2024 | ||
500 | |a Date Revised 19.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a BACKGROUND: Obesity is a well-known risk factor for gastroesophageal reflux disease (GERD). Even though symptoms may be mitigated or resolved with the weight loss caused by sleeve gastrectomy (SG), it may be associated with higher incidences of postoperative GERD. Ligamentum teres cardiopexy (LTC) is an alternative to Roux-en-Y gastric bypass, the gold standard treatment for GERD | ||
520 | |a METHODS: This study was a retrospective single-center chart review, all patients in this cohort underwent LTC to treat refractory GERD at our institution. The option for LTC was presented after patients' refusal to undergo RYGB conversion. We collected baseline characteristics, standard demographics, pre-operative tests and imaging, and SG information, as well as intraoperative and perioperative data regarding LTC, and postoperative complications | ||
520 | |a RESULTS: Our cohort included 29 patients; most were Caucasian (44.8%) females (86.2%). The mean weight and BMI before LTC were 216.5 ± 39.3 lb and 36.1 ± 5.4 kg/m2, respectively. Mean total body-weight loss (TBWL) at 12 and 24 months were 28.7% ± 9.5% and 28.4% ± 12.4%, respectively. The mean interval between the index bariatric surgery and LTC was 59.9 ± 34.9 months, mean operative time was 67 ± 18.2 min, and median length of stay (LOS) was 1 day (IQR = 1-2 days). Twelve patients (57.1%) were able to discontinue antisecretory medications, while 9 (42.9%) still required them to remain asymptomatic. Mortality and reoperation rates were 0% and the incidence of complication was 19.4% (n = 6) | ||
520 | |a CONCLUSIONS: LTC is a safe and effective surgical alternative to treat refractory GERD symptoms after SG | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biliopancreatic diversion with duodenal switch (BPD/DS) | |
650 | 4 | |a Gastroesophageal reflux disease (GERD) | |
650 | 4 | |a Ligamentum teres cardiopexy (LTC) | |
650 | 4 | |a Sleeve gastrectomy (SG) | |
700 | 1 | |a Antunes, Juliana |e verfasserin |4 aut | |
700 | 1 | |a Ghanem, Muhammad |e verfasserin |4 aut | |
700 | 1 | |a Jawad, Muhammad A |e verfasserin |4 aut | |
700 | 1 | |a Teixeira, Andre F |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Obesity surgery |d 1991 |g 34(2024), 4 vom: 24. Apr., Seite 1232-1237 |w (DE-627)NLM090631897 |x 1708-0428 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2024 |g number:4 |g day:24 |g month:04 |g pages:1232-1237 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11695-024-07103-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2024 |e 4 |b 24 |c 04 |h 1232-1237 |